Analysen von Charles Pitman-King

20.03.26 Sartorius Stedim Biotech Overweight Barclays Capital
20.03.26 Sartorius vz. Overweight Barclays Capital
18.03.26 Sartorius Stedim Biotech Overweight Barclays Capital
18.03.26 Sartorius vz. Overweight Barclays Capital
17.03.26 Sartorius Stedim Biotech Overweight Barclays Capital
17.03.26 Sartorius vz. Overweight Barclays Capital
16.03.26 Bayer Overweight Barclays Capital
12.03.26 Sartorius vz. Overweight Barclays Capital
11.03.26 Bayer Overweight Barclays Capital
09.03.26 Bayer Overweight Barclays Capital
05.03.26 Bayer Overweight Barclays Capital
04.03.26 Bayer Overweight Barclays Capital
19.02.26 Bayer Overweight Barclays Capital
18.02.26 Bayer Overweight Barclays Capital
06.02.26 Bayer Overweight Barclays Capital
05.02.26 Bayer Overweight Barclays Capital
04.02.26 Sartorius vz. Overweight Barclays Capital
03.02.26 Sartorius vz. Overweight Barclays Capital
07.01.26 Sartorius Stedim Biotech Overweight Barclays Capital
07.01.26 Sartorius vz. Overweight Barclays Capital
07.01.26 Bayer Overweight Barclays Capital
01.10.25 Sartorius Stedim Biotech Overweight Barclays Capital
01.10.25 Sartorius vz. Overweight Barclays Capital
23.07.25 Sartorius vz. Overweight Barclays Capital
18.06.25 Sartorius vz. Overweight Barclays Capital
12.05.25 Merck Overweight Barclays Capital
26.02.25 Sartorius vz. Overweight Barclays Capital